Get the Stockscreener App
24.01
2.34%
0.55
After Hours:
24.01
Castle Biosciences Inc stock is traded at $24.01, with a volume of 518.79K.
It is up +2.34% in the last 24 hours and up +47.94% over the past month.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
See More
Previous Close:
$23.46
Open:
$23.21
24h Volume:
518.79K
Relative Volume:
1.02
Market Cap:
$696.49M
Revenue:
$219.79M
Net Income/Loss:
$-57.47M
P/E Ratio:
-11.17
EPS:
-2.15
Net Cash Flow:
$-19.25M
1W Performance:
+15.21%
1M Performance:
+47.94%
6M Performance:
-5.02%
1Y Performance:
-19.40%
1-Day Range:
$22.95
$24.04
1-Week Range:
$20.35
$24.04
52-Week Range:
$14.59
$35.84
Castle Biosciences Inc Stock (CSTL) Company Profile
Name
Castle Biosciences Inc
Sector
Industry
Phone
866-788-9007
Address
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Compare CSTL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
24.01 | 680.53M | 219.79M | -57.47M | -19.25M | -2.15 |
|
TMO
Thermo Fisher Scientific Inc
|
492.72 | 184.93B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.82 | 147.00B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
647.09 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.66 | 35.50B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.81 | 32.08B | 15.70B | 1.24B | 2.01B | 6.91 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-07-22 | Initiated | Stephens | Overweight |
| Apr-30-21 | Initiated | Lake Street | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-27-19 | Reiterated | Canaccord Genuity | Buy |
| Aug-19-19 | Initiated | BTIG Research | Buy |
| Aug-19-19 | Initiated | Canaccord Genuity | Buy |
| Aug-19-19 | Initiated | Robert W. Baird | Outperform |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
View All
Castle Biosciences Inc Stock (CSTL) Latest News
How to forecast Castle Biosciences Inc. trends using time seriesJuly 2025 Update & Free Real-Time Market Sentiment Alerts - Newser
Should you wait for a breakout in Castle Biosciences Inc.2025 Price Action Summary & Weekly Market Pulse Alerts - Newser
Castle Biosciences Inc. stock outlook for YEARTrade Ideas & Weekly High Momentum Picks - Newser
Using economic indicators to assess Castle Biosciences Inc. potentialWeekly Market Report & Daily Profit Maximizing Trade Tips - Newser
Real time social sentiment graph for Castle Biosciences Inc.2025 Market Outlook & Free Risk Controlled Daily Trade Plans - Newser
Should you hold or exit Castle Biosciences Inc. nowWeekly Market Report & AI Optimized Trade Strategies - Newser
Ranking Castle Biosciences Inc. among high performing stocks via toolsJuly 2025 Decliners & Low Drawdown Investment Strategies - Newser
Castle Biosciences Inc. stock prediction for this weekTrade Analysis Report & Fast Gain Stock Trading Tips - Newser
News impact scoring models applied to Castle Biosciences Inc.Trade Volume Summary & Stock Market Timing Techniques - Newser
Can a trend reversal in Castle Biosciences Inc. lead to recoveryWeekly Stock Report & Momentum Based Trading Ideas - Newser
Will breakout in Castle Biosciences Inc. lead to full recoveryBull Run & Entry Point Confirmation Alerts - Newser
Using Ichimoku Cloud for Castle Biosciences Inc. technicalsEarnings Summary Report & Accurate Entry/Exit Alerts - Newser
Interpreting Recent Insider Sales at Castle Biosciences: A Cautionary Signal or Strategic Reallocation? - AInvest
Using data filters to optimize entry into Castle Biosciences Inc.July 2025 Institutional & Real-Time Stock Movement Alerts - Newser
Tools to monitor Castle Biosciences Inc. recovery probabilityMarket Activity Report & Free Technical Confirmation Trade Alerts - Newser
Castle Biosciences Insider Sells $390,572 Worth of Shares, SEC Filing Reveals - AInvest
What indicators show strength in Castle Biosciences Inc.Weekly Earnings Recap & Low Drawdown Investment Strategies - Newser
Visualizing Castle Biosciences Inc. stock with heatmaps2025 Macro Impact & AI Powered Market Trend Analysis - Newser
Castle Biosciences Inc Stock (CSTL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):